Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
1.
Thorax ; 70(3): 291-3, 2015 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-24764115

RESUMEN

Having established an ambulatory service for patients with suspected and proven PE, we reviewed our outcomes. All patients referred from June 2010 to May 2012 were analysed. Of 971 patients referred, 905 underwent complete assessment (66 admitted as ineligible). 754 (77.7%) patients were discharged and required no follow-up. 96 (10.6%) patients had PE confirmed of whom 70 (72.9%) were managed as outpatients. 14 (1.6%) patients have died since attending the clinic; no death was related to PE. This audit shows that ambulatory investigation and management of selected low risk patients with suspected PE is safe and reduces hospital admissions.


Asunto(s)
Atención Ambulatoria , Embolia Pulmonar/diagnóstico , Embolia Pulmonar/terapia , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Atención Ambulatoria/economía , Angiografía , Inglaterra , Femenino , Costos de la Atención en Salud , Hospitalización/economía , Humanos , Masculino , Auditoría Médica , Persona de Mediana Edad , Selección de Paciente , Embolia Pulmonar/economía , Tomografía Computarizada por Rayos X , Resultado del Tratamiento , Adulto Joven
3.
Thorax ; 66(12): 1078-84, 2011 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-21785158

RESUMEN

BACKGROUND: The treatment given to patients with lung cancer and survival vary between and within countries. The National Lung Cancer Audit (NLCA) linked to Hospital Episode Statistics was used to quantify the extent to which these outcomes are influenced by patient features and/or hospital facilities and performance indicators. METHODS: All patients with a histological diagnosis of non-small cell lung cancer (NSCLC) were included. Logistic regression was used to quantify the independent influence of features of both patients and hospitals on the likelihood of having surgery and Cox regression was used for survival analyses. RESULTS: There were 34,513 patients with NSCLC in our dataset. After adjusting for age, sex, performance status, stage and Charlson Index of comorbidity, patients with NSCLC first seen in thoracic surgical centres (27% of the cohort) were 51% more likely to have surgery than those seen in non-surgical centres (adjusted OR 1.51, 95% CI 1.16 to 1.97). Resection rates varied from 13% to 17% between non-surgical and thoracic surgical centres. Surgery was the most powerful determinant of overall survival (adjusted HR 0.41, 95% CI 0.39 to 0.44). CONCLUSION: A minority of patients with NSCLC first seen in a thoracic surgical centre are more likely to have surgery and to benefit from the survival advantage this confers. This finding suggests that there is an opportunity to improve the outcome for patients with lung cancer in England by optimising access to thoracic surgeons in non-surgical centres.


Asunto(s)
Carcinoma de Pulmón de Células no Pequeñas/cirugía , Neoplasias Pulmonares/cirugía , Adulto , Anciano , Anciano de 80 o más Años , Carcinoma de Pulmón de Células no Pequeñas/mortalidad , Carcinoma de Pulmón de Células no Pequeñas/patología , Comorbilidad , Inglaterra/epidemiología , Femenino , Accesibilidad a los Servicios de Salud , Hospitales , Humanos , Modelos Logísticos , Neoplasias Pulmonares/mortalidad , Neoplasias Pulmonares/patología , Masculino , Persona de Mediana Edad , Neumonectomía/estadística & datos numéricos , Modelos de Riesgos Proporcionales , Calidad de la Atención de Salud , Análisis de Supervivencia , Resultado del Tratamiento
4.
Respirology ; 15(1): 71-9, 2010 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-19895387

RESUMEN

Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) offers a minimally invasive option for staging the mediastinum in suspect lung cancer but also in the diagnosis of mediastinal lesions accessible from the airway. This review is aimed at centres considering establishing an EBUS service that may not be so familiar with the technique. It focuses primarily on technical aspects of EBUS-TBNA, training issues, cost considerations, indications, advantages and disadvantages compared with other mediastinal sampling techniques as well as some reference to its performance in clinical studies. In summary, EBUS-TBNA is primarily used for staging non-small cell lung cancer, especially for bulky mediastinal disease and discrete N2 or N3 disease on CT, but also used for the diagnosis of unexplained mediastinal lymphadenopathy. For radical treatment staging, mediastinoscopy is still used at many centres and negative EBUS-TBNA results should be corroborated by mediastinoscopy. In the future, EBUS-TBNA may be used for staging the radiologically normal mediastinum and in re-staging. It is a procedure that can be taught with ease by an experienced operator, has numerous advantages over mediastinoscopy and is potentially cost saving by reducing the number of mediastinoscopies and associated peri-operative support required.


Asunto(s)
Biopsia con Aguja/métodos , Broncoscopía/métodos , Carcinoma de Pulmón de Células no Pequeñas/patología , Neoplasias Pulmonares/patología , Ultrasonografía Intervencional/métodos , Biopsia con Aguja/efectos adversos , Biopsia con Aguja/economía , Pérdida de Sangre Quirúrgica/prevención & control , Broncoscopía/efectos adversos , Broncoscopía/economía , Carcinoma de Pulmón de Células no Pequeñas/diagnóstico , Humanos , Neoplasias Pulmonares/diagnóstico , Ganglios Linfáticos/patología , Metástasis Linfática , Mediastinoscopía , Estadificación de Neoplasias , Ultrasonografía Intervencional/efectos adversos , Ultrasonografía Intervencional/economía
5.
Respirology ; 15(5): 804-8, 2010 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-20456669

RESUMEN

BACKGROUND AND OBJECTIVE: Medical thoracoscopy (MT) is indicated for the investigation of unexplained pleural exudates. Not all MT units create artificial pneumothoraces because of time. Difficult pleural space access and thick fibrous adhesions may prevent MT and pleurodesis, respectively. The potential role of thoracic ultrasound (TUS) pre-MT has not been fully evaluated. We hypothesized TUS would reduce failure to access the pleural space and enable detection of thick fibrous adhesions. METHODS: Thirty patients underwent single port MT consecutively for investigation of pleural exudates without pre-MT TUS over a 6-month period. Over the following 6 months, 30 consecutive patients underwent TUS immediately prior to MT. Pleural access rate and thick fibrous adhesion detection at both MT and TUS were recorded. RESULTS: In the non-TUS cohort, pleural space access failure occurred in 16.7% (leading to five extra procedures), versus no failures in the TUS cohort (P = 0.0522). There were no differences in prevalence of MT fibrous adhesions between cohorts. TUS identified all cases of fibrous septation versus only 12.5% identified by CT in the non-TUS cohort (P = 0.001). All identified cases of thick fibrous septation on TUS did not receive pleurodesis at MT. TUS detected useful ancillary features in 43% of cases. CONCLUSIONS: A strong trend to reduction in single port MT pleural access failure was noted with pre-MT TUS thus reducing extra procedures and the need for artificial pneumothoraces. Pre-MT TUS also reliably detects thick fibrous adhesions at MT. TUS may also detect useful ancillary features. This study provides a rationale for ultrasound-guided single port MT if a pneumothorax is not created.


Asunto(s)
Cavidad Pleural/diagnóstico por imagen , Cavidad Pleural/cirugía , Pared Torácica/diagnóstico por imagen , Pared Torácica/cirugía , Toracoscopía , Anciano , Femenino , Humanos , Masculino , Enfermedades Pleurales/diagnóstico , Derrame Pleural/diagnóstico por imagen , Derrame Pleural/cirugía , Pleurodesia , Neumotórax Artificial , Estudios Prospectivos , Adherencias Tisulares/diagnóstico , Resultado del Tratamiento , Ultrasonografía
6.
Curr Opin Pulm Med ; 15(4): 334-42, 2009 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-19395972

RESUMEN

PURPOSE OF REVIEW: There is increasing awareness of minimally invasive endoscopic techniques for mediastinal staging in lung cancer. Traditionally, cervical mediastinoscopy has been utilized. Endobronchial ultrasound-guided fine needle aspiration (EBUS) has recently emerged as a potential alternative. RECENT FINDINGS: EBUS has sensitivity for lung cancer which is at least equivalent (if not superior) to cervical mediastinoscopy. However, cervical mediastinoscopy remains superior to EBUS and other techniques in its high negative predictive value. More recent data suggest EBUS may have a role in presurgical staging of radiologically normal subcentimetre nodes and its negative predictive value may be equivalent to surgical staging. Ongoing comparative studies between EBUS and cervical mediastinoscopy may well clarify relative performance and cost analyses. SUMMARY: Currently, insufficient data are present to recommend replacing cervical mediastinoscopy with EBUS for lung cancer staging; the negative predictive value of EBUS requires validation. However, EBUS can be recommended for initial staging as a minimally invasive option provided negative results are followed by cervical mediastinoscopy. This would also allow cervical mediastinoscopy to be reserved for re-staging. Conventional transbronchial needle aspiration has a limited role only as a first-line staging procedure but may aid diagnosis. In the future, EBUS may have a role in presurgical staging of the radiologically normal mediastinum and re-staging if prior staging is done by cervical mediastinoscopy.


Asunto(s)
Neoplasias Pulmonares/diagnóstico por imagen , Neoplasias Pulmonares/patología , Mediastino/diagnóstico por imagen , Mediastino/patología , Biopsia con Aguja Fina/economía , Biopsia con Aguja Fina/métodos , Costos y Análisis de Costo , Humanos , Mediastinoscopía/economía , Mediastinoscopía/métodos , Estadificación de Neoplasias , Ultrasonografía
7.
BMJ Open Respir Res ; 5(1): e000281, 2018.
Artículo en Inglés | MEDLINE | ID: mdl-29955362

RESUMEN

The following is a summary of the recommendations and good practice points for the BTS Guideline for the initial outpatient management of pulmonary embolism. Please refer to the full guideline for full information about each section.

8.
Lung Cancer ; 72(1): 16-22, 2011 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-20688413

RESUMEN

AIMS: Our aims were to determine whether the information in the National Lung Cancer Audit database (LUCADA) is influenced by the completeness of reporting and to describe the current socio-demographics and survival of people with lung cancer in England. METHODS: Using national registry data as a gold standard we stratified NHS Trusts into quartiles on the basis of their patient ascertainment. We assessed the distribution of patient features across these quartiles using Cox and logistic regression. We then examined overall survival and access to treatment. RESULTS: We analysed data for 60,059 patients whose data were entered between 2004 and 2008. There was little variation in key patient features, treatment and median survival across quartiles of data completeness. Socio-economic disadvantage did not influence survival or access to surgery but was related to a decreased use of chemotherapy. CONCLUSION: Our findings suggest that LUCADA accurately describes people in England who are diagnosed with lung cancer and can therefore be used to drive health care improvements. Individual patient socio-economic status does not affect survival and has only a limited impact on access to treatment and so NHS Trust level factors should be studied to explain the previously published regional variations in these outcomes.


Asunto(s)
Neoplasias Pulmonares/epidemiología , Auditoría Médica , Sistema de Registros , Anciano , Inglaterra/epidemiología , Femenino , Humanos , Neoplasias Pulmonares/economía , Neoplasias Pulmonares/mortalidad , Neoplasias Pulmonares/terapia , Masculino , Persona de Mediana Edad
9.
Clin Chest Med ; 31(1): 165-72, Table of Contents, 2010 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-20172442

RESUMEN

Medical pleuroscopy (MP) offers a safe and minimally invasive tool for interventional pulmonologists. It allows diagnosis of unexplained effusion, while at the same time allowing drainage and pleurodesis. It can also help in the diagnosis of diffuse interstitial disease or associated peripheral lung abnormality in the presence of effusion. It can have a therapeutic role in pneumothorax and hyperhidrosis or chronic pancreatic pain. This article reviews the technical aspects and range of applications of MP.


Asunto(s)
Enfermedades Pleurales/cirugía , Toracoscopía , Humanos , Hiperhidrosis/cirugía , Enfermedades Pulmonares Intersticiales/diagnóstico , Derrame Pleural/diagnóstico , Derrame Pleural/cirugía , Neumotórax/cirugía , Toracoscopía/economía , Toracoscopía/métodos , Tuberculosis Pleural/cirugía
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA